Patients with prediabetes and severe obesity who underwent metabolic surgery, such as Roux-en-Y gastric bypass or sleeve gastrectomy, significantly reduced their risk of developing type 2 diabetes over a 15-year period compared to those who did not have surgery. Metabolic surgery greatly lowers the risk of developing type 2 diabetes in severely obese patients with prediabetes, offering both treatment and prevention benefits. Those undergoing surgery like gastric bypass showed a marked decrease in diabetes onset and maintained significant weight loss.
Patients with pre-diabetes and severe obesity who had metabolic and bariatric surgery were 20 times less likely to develop full-blown type 2 diabetes over the course of 15 years than patients with the condition who did not have surgery. This is according to a new study entitled “The Long Term (15 year) Impact of Bariatric Surgery on Conversion from Pre-Diabetes to Type II Diabetes Mellitus” that will be presented today (June 11) at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2024 Annual Scientific Meeting. Long-Term Benefits of Bariatric Surgery Only 1.
8% of patients progressed to a diagnosis of diabetes in five years after metabolic surgery (Roux-en-Y gastric bypass or sleeve gastrectomy), which rose to 3.3% in 10 years and 6.7% after 15 years.
The protective effect against diabetes was higher among gastric bypass patients. Meanwhile, nearly a third (31.1%) of patients with no prior metabolic surgery saw.